196 related articles for article (PubMed ID: 28238065)
1. Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.
Hochstrasser T; Exner GL; Nyamoya S; Schmitz C; Kipp M
J Mol Neurosci; 2017 Apr; 61(4):617-624. PubMed ID: 28238065
[TBL] [Abstract][Full Text] [Related]
2. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.
Tejedor LS; Wostradowski T; Gingele S; Skripuletz T; Gudi V; Stangel M
J Mol Neurosci; 2017 Apr; 61(4):479-488. PubMed ID: 28124770
[TBL] [Abstract][Full Text] [Related]
4. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice.
Irvine KA; Blakemore WF
J Neuroimmunol; 2006 Jun; 175(1-2):69-76. PubMed ID: 16626812
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural abnormalities and loss of myelinated fibers in the corpus callosum of demyelinated mice induced by cuprizone.
Xiu Y; Cheng GH; Peng C; Wang Y; Li YD; Chao FL; Tang Y
J Neurosci Res; 2017 Aug; 95(8):1677-1689. PubMed ID: 27935632
[TBL] [Abstract][Full Text] [Related]
6. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
Taylor LC; Gilmore W; Ting JP; Matsushima GK
J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum.
Sun SW; Liang HF; Trinkaus K; Cross AH; Armstrong RC; Song SK
Magn Reson Med; 2006 Feb; 55(2):302-8. PubMed ID: 16408263
[TBL] [Abstract][Full Text] [Related]
8. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Skripuletz T; Lindner M; Kotsiari A; Garde N; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Am J Pathol; 2008 Apr; 172(4):1053-61. PubMed ID: 18349131
[TBL] [Abstract][Full Text] [Related]
9. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
Nomura T; Bando Y; You H; Tanaka T; Yoshida S
Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
11. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory demyelination alters subcortical visual circuits.
Araújo SES; Mendonça HR; Wheeler NA; Campello-Costa P; Jacobs KM; Gomes FCA; Fox MA; Fuss B
J Neuroinflammation; 2017 Aug; 14(1):162. PubMed ID: 28821276
[TBL] [Abstract][Full Text] [Related]
13. Cuprizone feed formulation influences the extent of demyelinating disease pathology.
Toomey LM; Papini M; Lins B; Wright AJ; Warnock A; McGonigle T; Hellewell SC; Bartlett CA; Anyaegbu C; Fitzgerald M
Sci Rep; 2021 Nov; 11(1):22594. PubMed ID: 34799634
[TBL] [Abstract][Full Text] [Related]
14. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
15. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Hiremath MM; Saito Y; Knapp GW; Ting JP; Suzuki K; Matsushima GK
J Neuroimmunol; 1998 Dec; 92(1-2):38-49. PubMed ID: 9916878
[TBL] [Abstract][Full Text] [Related]
16. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Guglielmetti C; Veraart J; Roelant E; Mai Z; Daans J; Van Audekerke J; Naeyaert M; Vanhoutte G; Delgado Y Palacios R; Praet J; Fieremans E; Ponsaerts P; Sijbers J; Van der Linden A; Verhoye M
Neuroimage; 2016 Jan; 125():363-377. PubMed ID: 26525654
[TBL] [Abstract][Full Text] [Related]
17. Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss.
Doan V; Kleindienst AM; McMahon EJ; Long BR; Matsushima GK; Taylor LC
J Neurosci Res; 2013 Mar; 91(3):363-73. PubMed ID: 23280518
[TBL] [Abstract][Full Text] [Related]
18. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs P; Selak MA; Komoly S; Kalman B
J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
[TBL] [Abstract][Full Text] [Related]
19. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Thiessen JD; Zhang Y; Zhang H; Wang L; Buist R; Del Bigio MR; Kong J; Li XM; Martin M
NMR Biomed; 2013 Nov; 26(11):1562-81. PubMed ID: 23943390
[TBL] [Abstract][Full Text] [Related]
20. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
Goldberg J; Clarner T; Beyer C; Kipp M
J Mol Neurosci; 2015 Oct; 57(2):166-75. PubMed ID: 26067430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]